The Interaction of Patient Perception of Overmedication with Drug Compliance and Side Effects
Overview
Authors
Affiliations
Objective: Little is known about the significance of patient-perceived overmedication. We sought to determine its prevalence and relation to medication compliance, adverse drug reactions, health-related quality of life (HRQOL), and burden of illness.
Design: Analysis of self-reported questionnaire data. PATIENTS/PARTICIPANT: There were 1,648 participants in a longitudinal study of male veterans.
Intervention: Participants listed each of their medications with indication, missed doses, adverse reactions, and whether their amount of medication was "too much, the right amount, or too little." The survey included questions about medication adherence, "problems with medications," common symptoms, and screening questions for a number of chronic conditions. We assessed HRQOL with the Multiple Outcomes Study 36-Item Short Form Health Study (SF-36).
Measurements And Main Results: Of the 1,256 respondents, 1,007 (80%) had taken medication within 4 weeks. Forty (4%) thought they were taking too much. They reported a 1.6-fold increase in prescription medications, a 5-8 fold increase in adverse effects, a 1.5-2 fold decrease in compliance, an increase in each of seven measured symptoms, and a decrease in six of eight SF-36 domains (p < .05 for all comparisons), the exceptions being the mental health and role-emotional scales. There was also a slight increase in the report of any chronic illness (95% vs 86%, p > .05).
Conclusions: Patient perception of overmedication correlates with self-report of decreased compliance, adverse drug reactions, decreased HRQOL, and an increase in symptomatology that is compatible with unrecognized side effects of medication. Such patients warrant careful evaluation.
Payne R, Blair P, Caddick B, Chew-Graham C, Dreischulte T, Duncan L NIHR Open Res. 2023; 2:54.
PMID: 37881305 PMC: 10593356. DOI: 10.3310/nihropenres.13285.1.
Effects of Language, Age, and Hearing Loss on Health-Related Quality of Life.
Ma H, Reyes Orozco F, Raj C, Herrera K, Parsons J, Kim I OTO Open. 2023; 7(2):e55.
PMID: 37251543 PMC: 10225048. DOI: 10.1002/oto2.55.
Vidonscky Luthold R, Jungo K, Weir K, Geier A, Scholtes B, Kurpas D BMC Geriatr. 2022; 22(1):920.
PMID: 36451180 PMC: 9709365. DOI: 10.1186/s12877-022-03562-x.
Analysis of Various Factors Associated With Opioid Dose Escalation in Patients With Cancer Pain.
Sakamoto R, Koyama A Cureus. 2022; 14(5):e25266.
PMID: 35755532 PMC: 9224761. DOI: 10.7759/cureus.25266.
Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients.
Kamal K, Charrow A, LaChance A J Clin Aesthet Dermatol. 2021; 14(2):12.
PMID: 34221220 PMC: 8211342.